Additional treatment for pT3 prostate cancer: now, later or never.
Dearnaley
David P
DP
Academic Radiotherapy, Institute of Cancer Research, Sutton, Surrey, UK.
D000368:Aged; D003131:Combined Modality Therapy; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000628:therapy*; D013997:Time Factors